BLOOD INSULIN INCREASED side effect
What is BLOOD INSULIN INCREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
BLOOD INSULIN INCREASED and Recently Reported Side Effects
BLOOD INSULIN INCREASED and 15 most Active Side Effect polls
BLOOD INSULIN INCREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with BLOOD INSULIN INCREASED
ATAZANAVIR AVANDAMET AVANDIA BYETTA CRESTOR DIPROPHOS FLUOROURACIL MIRENA NOVORAPID OXYCONTIN SYMLIN TERNELIN TRAZODONE VENLAFAXIINEFluorouracil Side Effects Report #5594648-9
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Jan 17, 2008. Male patient, 68 years of age, weighting 221.0 lb, was diagnosed with pancreatic neuroendocrine tumour and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, diarrhoea, hypoglycaemia, neuropathy peripheral, . FLUOROURACIL dosage: 5540MG, Q3W, IV. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN. Patient was hospitalized. Patient recovered.
Avandamet Side Effects Report #5512475-5
AVANDAMET problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Female patient, 57 years of age, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, . AVANDAMET dosage: unknown. During the same period patient was treated with THYROID, HYZAAR, HUMALOG, HUMULIN R. Patient recovered.
Trazodone Side Effects Report #5527863-0
Consumer or non-health professional from ITALY reported TRAZODONE problem on Nov 26, 2007. Female patient, 31 years of age, was diagnosed with anxiety and was treated with TRAZODONE. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, . TRAZODONE dosage: unknown. During the same period patient was treated with HUMALOG, INSULIN GLARGINE, LEVOTHYROXINE, SERTRALINE. Patient recovered.
Ternelin Side Effects Report #5448312-7
TERNELIN problem was reported by a Physician from JAPAN on Aug 25, 2007. Female patient, weighting 16.09 lb, was diagnosed with hypertonia and was treated with TERNELIN. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, diarrhoea, hyperglycaemia, hyperhidrosis, hypoglycaemia, insulin c-peptide increased, pallor, pneumonia, . TERNELIN dosage: 1.5 MG QD ORAL. During the same period patient was treated with DANTRIUM, DEPAKENE, LANSOPRAZOLE, TRICLORYL, MUCODYNE, MUCOSAL, KLARICID. Patient was hospitalized. Patient recovered.
Ternelin Side Effects Report #5408394-5
Physician from JAPAN reported TERNELIN problem on July 21, 2007. Female patient, weighting 16.09 lb, was diagnosed with hypertonia and was treated with TERNELIN. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, diarrhoea, hyperhidrosis, hypoglycaemia, insulin c-peptide increased, pallor, pneumonia, . TERNELIN dosage: 1.5 MG QD ORAL. During the same period patient was treated with DANTRIUM, DEPAKENE, LANSOPRAZOLE, TRICLORYL, MUCODYNE, MUCOSAL, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.
Byetta Side Effects Report #5429734-7
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 26 years of age, was diagnosed with insulin resistance and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE PEN. Patient recovered.
Byetta Side Effects Report #5429734-7
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Apr 13, 2007. Female patient, 26 years of age, was diagnosed with insulin resistance and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE PEN. Patient recovered.
Diprophos Side Effects Report #5713610-6
DIPROPHOS problem was reported by a Physician from BELGIUM on Apr 09, 2008. Female patient, 59 years of age, was treated with DIPROPHOS. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, headache, hypoglycaemia, road traffic accident, urine ketone body present, . DIPROPHOS dosage: unknown. During the same period patient was treated with BELSAR. Patient was hospitalized. Patient recovered.
Symlin Side Effects Report #5355335-5
Physician from UNITED STATES reported SYMLIN problem on May 23, 2007. Female patient, 24 years of age, weighting 132.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with SYMLIN. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, dizziness, hypoglycaemia, loss of consciousness, nausea, . SYMLIN dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.
Avandia Side Effects Report #5316885-0
AVANDIA problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2007. Female patient, 36 years of age, was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, hepatic enzyme increased, oedema peripheral, . AVANDIA dosage: 4MG SEE TEXT. During the same period patient was treated with LISINOPRIL, PROVERA, ZANTAC, LASIX, ALDACTONE. Patient recovered.
Crestor Side Effects Report #5239006-1
Physician from UNITED STATES reported CRESTOR problem on June 16, 2005. Female patient, 53 years of age, was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: blood insulin increased, myalgia, . CRESTOR dosage: 5 MG PO. Patient recovered.
Atazanavir Side Effects Report #5689140-7
ATAZANAVIR SULPHATE problem was reported by a Health Professional from UNITED STATES on Mar 25, 2008. Female patient, child 5 years of age, weighting 41.89 lb, was diagnosed with hiv infection and was treated with ATAZANAVIR SULPHATE. After drug was administered, patient experienced the following problems/side effects: acanthosis nigricans, blood insulin increased, dyslipidaemia, hyperkeratosis, keratosis pilaris, skin hyperpigmentation, . ATAZANAVIR SULPHATE dosage: STARTED-}150MG: 22DEC03-25JAN05, 200MG 26JAN2005-27AUG2007, 250MG FROM 28AUG2007-}CONTINUES. Patient recovered.
Novorapid Side Effects Report #5536899-5
Physician from JAPAN reported NOVORAPID problem on Nov 27, 2007. Male patient, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, nerve injury, peripheral vascular disorder, constipation and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody increased, blood insulin increased, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID CHU FLEXPEN, NOVOLIN R, GLYBURIDE, GLUFAST, BASEN, METHYCOBAL, JUVELA N, MAGLAX. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5490350-2
NOVORAPID problem was reported by a Physician from JAPAN on Oct 10, 2007. Male patient, 78 years of age, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, nerve injury, peripheral vascular disorder, constipation and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody increased, blood insulin increased, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID CHU, NOVOLIN N, GLYBURIDE, GLUFAST, BASEN, METHYCOBAL, JUVELA N, MAGLAX. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5498699-4
Physician from JAPAN reported NOVORAPID problem on Oct 19, 2007. Male patient, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, nerve injury, peripheral vascular disorder, constipation and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody increased, blood insulin increased, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID CHU FLEXPEN, NOVOLIN R, GLYBURIDE, GLUFAST, BASEN, METHYCOBAL, JUVELA N, MAGLAX. Patient was hospitalized. Patient recovered.
Mirena Side Effects Report #5496182-3
MIRENA BAYER problem was reported by a Consumer or non-health professional from VENEZUELA on Sept 26, 2007. Female patient, weighting 233.7 lb, was diagnosed with contraception and was treated with MIRENA BAYER. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, blood insulin increased, weight increased, . MIRENA BAYER dosage: unknown. Patient recovered.
Venlafaxiine Side Effects Report #5429859-6
Physician from NETHERLANDS reported VENLAFAXIINE problem on Aug 13, 2007. Male patient, 29 years of age, was diagnosed with incorrect dose administered and was treated with VENLAFAXIINE. After drug was administered, patient experienced the following problems/side effects: agitation, blood insulin increased, blood pressure increased, clonus, depressed level of consciousness, eye movement disorder, gastric lavage, hypoglycaemia, insulin c-peptide increased, . VENLAFAXIINE dosage: unknown. During the same period patient was treated with OXAZEPAM. Patient was hospitalized. Patient recovered.
Oxycontin Side Effects Report #5352003-0
OXYCONTIN problem was reported by a Consumer or non-health professional from AUSTRALIA on June 01, 2007. Male patient, 34 years of age, was diagnosed with neuroendocrine tumour and was treated with OXYCONTIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood insulin increased, brain damage, brain hypoxia, glasgow coma scale abnormal, hypoglycaemic coma, insulin c-peptide increased, intubation, resuscitation, . OXYCONTIN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, DEXAMETHASONE, SANDOSTATIN LAR. Patient was hospitalized. Patient died on 08/24/2005.